BHVN

Biohaven Ltd.NYSEHealthcare

$9.80+1.87%ClosedMarket Cap: $1.04B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-11	TD Cowen	—	Buy	—
2026-03-04	HC Wainwright & Co.	—	Neutral	—
2026-03-03	RBC Capital	—	Outperform	—
2026-01-21	RBC Capital	—	Outperform	—
2026-01-06	Morgan Stanley	—	Overweight	—
2025-12-26	HC Wainwright & Co.	—	Neutral	—
2025-11-26	UBS	—	Neutral	—
2025-11-20	JP Morgan	—	Overweight	—
2025-11-18	BTIG	—	Buy	—
2025-11-18	Morgan Stanley	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.55	$19.7M	10
Sun Dec 31	$-2.25	$112.5M	11
Mon Dec 31	$-1.47	$325.5M	4
Tue Dec 31	$0.26	$779.9M	4